CANCER RESEARCH AND GENETICS UK

Registered charity 1121512 · accounts filings on the Charity Commission register

Provides information on Cancer Research and its Genetic links and supports the purchase of Cancer Research equipment at the major Institutes and Universities in the UK. Support cancer patients and to provide respite and convalescence and advice on therapies to aid the recovery from cancer treatments.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£128k
Latest spending
£113k
Registered
2007
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity held unrestricted reserves of £137,096.66 at the end of the financial year, which the trustees declare is held to meet unforeseen expenditure. The charity reported a net income of £14,864 for the year, derived from incoming resources of £128,309 against total resources expended of £113,445.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: to meet any unforeseen expenditure that may occur (held: £137k)
We hold cash at bank of £137096.66 which is held in reserve to meet any unforeseen expenditure that may occur
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
07/11/2025£128k£113k
07/11/2024£95k£60k
07/11/2023£62k£83k
07/11/2022£94k£16k
07/11/2021£82k£55k

Common questions

Is CANCER RESEARCH AND GENETICS UK financially healthy?

Per its FY2025 accounts: The accounts state that the charity held unrestricted reserves of £137,096.66 at the end of the financial year, which the trustees declare is held to meet unforeseen expenditure. The charity reported a net income of £14,864 for the year, derived from incoming resources of £128,309 against total resources expended of £113,445. Its FY2025 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with THE CANCER TREATMENT AND RESEARCH TRUST CIO.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
CANCER RESEARCH AND GENETICS UK£128k0unclearno doubt
THE CANCER TREATMENT AND RESEARCH TRUST CIO FY2024£502k0aboveno doubt
CANCER RESEARCH UK FY2025£734.8m£250,001 - £260,000380above22.0%no doubt
CANCER RESEARCH WALES FY2025£5.9munclearno doubt
BREAST CANCER RESEARCH AID (BCRA) FY2024£123k0withinno doubt
CANCER SUPPORT UK (CSUK) FY2024£540k£80,001 - £90,0001unclearno doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.